Gilead Sciences (GILD) EBIT Margin (2009 - 2026)
Gilead Sciences posted quarterly EBIT Margin of 37.16% for Q1 2026, up 360.0% year-on-year from 8.08% in Q1 2025, and up 48.41% on a QoQ basis from 25.03% in Q4 2025.
Gilead Sciences (GILD) has 18 years of EBIT Margin data on file, last reported at 37.16% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin rose 360.0% year-over-year to 37.16%; the trailing twelve-month figure through Mar 2026 stood at 34.88% (up 627.0% YoY), and the FY2025 full-year result was 34.04%, up 2826.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 37.16%, up from 25.03% in the prior quarter.
- Across five years, EBIT Margin topped out at 42.82% in Q3 2025 and bottomed at 64.64% in Q1 2024.
- The 5-year median for EBIT Margin is 32.4% (2024), against an average of 24.08%.
- The widest annual swing landed in 2024, when EBIT Margin tumbled 9148 bps; it then soared 9820 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 30.68% in 2022, then slipped by 26 bps to 22.66% in 2023, then soared by 43 bps to 32.4% in 2024, then declined by 23 bps to 25.03% in 2025, then surged by 48 bps to 37.16% in 2026.
- The last three EBIT Margin figures came in at 37.16% (Q1 2026), 25.03% (Q4 2025), and 42.82% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 47.98% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 26.44% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 26.60% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -47.46% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 30.94% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 37.16% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -286.83% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.58% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.16% |
| Dec 31, 2025 | 25.03% |
| Sep 30, 2025 | 42.82% |
| Jun 30, 2025 | 34.93% |
| Mar 31, 2025 | 33.55% |
| Dec 31, 2024 | 32.40% |
| Sep 30, 2024 | 11.77% |
| Jun 30, 2024 | 38.02% |
| Mar 31, 2024 | -64.64% |
| Dec 31, 2023 | 22.66% |
| Sep 30, 2023 | 37.20% |
| Jun 30, 2023 | 25.23% |
| Mar 31, 2023 | 26.84% |
| Dec 31, 2022 | 30.68% |
| Sep 30, 2022 | 40.29% |
| Jun 30, 2022 | 32.41% |
| Mar 31, 2022 | 2.99% |
| Dec 31, 2021 | 12.98% |
| Sep 30, 2021 | 51.77% |
| Jun 30, 2021 | 36.13% |
| Mar 31, 2021 | 44.99% |
| Dec 31, 2020 | 35.72% |
| Sep 30, 2020 | 30.42% |
| Jun 30, 2020 | -58.00% |
| Mar 31, 2020 | 43.29% |
| Dec 31, 2019 | 18.59% |
| Sep 30, 2019 | -26.28% |
| Jun 30, 2019 | 42.74% |
| Mar 31, 2019 | 42.36% |
| Dec 31, 2018 | 19.74% |
| Sep 30, 2018 | 46.87% |
| Jun 30, 2018 | 40.37% |
| Mar 31, 2018 | 42.32% |
| Dec 31, 2017 | 11.35% |
| Sep 30, 2017 | 58.54% |
| Jun 30, 2017 | 59.57% |
| Mar 31, 2017 | 57.91% |
| Dec 31, 2016 | 55.26% |
| Sep 30, 2016 | 58.65% |
| Jun 30, 2016 | 58.36% |
| Mar 31, 2016 | 59.67% |
| Dec 31, 2015 | 66.08% |
| Sep 30, 2015 | 67.33% |
| Jun 30, 2015 | 68.12% |
| Mar 31, 2015 | 70.73% |
| Dec 31, 2014 | 59.20% |
| Sep 30, 2014 | 57.60% |
| Jun 30, 2014 | 67.51% |
| Mar 31, 2014 | 60.87% |
| Dec 31, 2013 | 38.37% |
| Sep 30, 2013 | 41.25% |
| Jun 30, 2013 | 41.70% |
| Mar 31, 2013 | 40.49% |
| Dec 31, 2012 | 42.76% |
| Sep 30, 2012 | 43.02% |
| Jun 30, 2012 | 44.03% |
| Mar 31, 2012 | 35.06% |
| Dec 31, 2011 | 39.42% |
| Sep 30, 2011 | 47.31% |
| Jun 30, 2011 | 47.57% |
| Mar 31, 2011 | 46.83% |
| Dec 31, 2010 | 41.50% |
| Sep 30, 2010 | 50.53% |
| Jun 30, 2010 | 51.51% |
| Mar 31, 2010 | 55.67% |
| Dec 31, 2009 | 52.42% |
| Sep 30, 2009 | 49.65% |
| Jun 30, 2009 | 46.20% |
| Mar 31, 2009 | 52.82% |